 | • レポートコード：20QY06-08190 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、皮膚科薬のグローバル市場について種類別（外用、経口、注射）、用途別（乾癬、皮膚感染症、にきび、皮膚炎、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・皮膚科薬市場の概要 ・世界の主要地域別皮膚科薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の皮膚科薬市場規模2015-2026：種類別（外用、経口、注射） ・世界の皮膚科薬市場規模2015-2026：用途別（乾癬、皮膚感染症、にきび、皮膚炎、その他） ・皮膚科薬の北米市場規模2015-2020 ・皮膚科薬のヨーロッパ市場規模2015-2020 ・皮膚科薬の中国市場規模2015-2020 ・皮膚科薬の日本市場規模2015-2020 ・皮膚科薬の東南アジア市場規模2015-2020 ・皮膚科薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AbbVie、Johnson & Johnson、Bayer、Galderma、Bristol-Myers Squibb、Novartis、Pfizer、Merz Pharma、Valeant、LEO Pharma、GlaxoSmithKline） ・皮膚科薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・皮膚科薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Dermatology Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Dermatology Drug market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Dermatology Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Dermatology Drug industry.
Based on our recent survey, we have several different scenarios about the Dermatology Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Dermatology Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Dermatology Drug market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Dermatology Drug market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Dermatology Drug market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Dermatology Drug market. The report also includes nautical information, where it shows Dermatology Drug market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Dermatology Drug market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Dermatology Drug market.
The classification of Dermatology Drug includes External Use, Oral and Injection, and the revenue proportion of External Use in 2015 is about 73.74%.
Geographical Analysis:
Based on region, the global Dermatology Drug market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Dermatology Drug market are
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Segment by Type
External Use
Oral
Injection
Segment by Application
Psoriasis
Skin Infections
Acne
Dermatitis
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Dermatology Drug market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Dermatology Drug market.
• The market share of the global Dermatology Drug market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Dermatology Drug market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Dermatology Drug market.
1 Dermatology Drug Market Overview
1.1 Dermatology Drug Product Scope
1.2 Dermatology Drug Segment by Type
1.2.1 Global Dermatology Drug Sales by Type (2020-2026)
1.2.2 External Use
1.2.3 Oral
1.2.4 Injection
1.3 Dermatology Drug Segment by Application
1.3.1 Global Dermatology Drug Sales Comparison by Application (2020-2026)
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Other
1.4 Dermatology Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Dermatology Drug Sales Growth Rate (2015-2026)
1.4.2 Global Dermatology Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Dermatology Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Dermatology Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Dermatology Drug Industry
1.5.1.1 Dermatology Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Dermatology Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Dermatology Drug Players to Combat Covid-19 Impact
2 Dermatology Drug Estimate and Forecast by Region
2.1 Global Dermatology Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Dermatology Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Dermatology Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Dermatology Drug Revenue Market Share by Region (2015-2020)
2.3 Global Dermatology Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Dermatology Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Dermatology Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dermatology Drug Estimates and Projections (2015-2026)
2.4.2 Europe Dermatology Drug Estimates and Projections (2015-2026)
2.4.3 China Dermatology Drug Estimates and Projections (2015-2026)
2.4.4 Japan Dermatology Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Dermatology Drug Estimates and Projections (2015-2026)
2.4.6 India Dermatology Drug Estimates and Projections (2015-2026)
3 Global Dermatology Drug Competition Landscape by Players
3.1 Global Top Dermatology Drug Players by Sales (2015-2020)
3.2 Global Top Dermatology Drug Players by Revenue (2015-2020)
3.3 Global Dermatology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology Drug as of 2019)
3.4 Global Dermatology Drug Average Price by Company (2015-2020)
3.5 Manufacturers Dermatology Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Dermatology Drug Players (Opinion Leaders)
4 Global Dermatology Drug Market Size by Type
4.1 Global Dermatology Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Dermatology Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Dermatology Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Dermatology Drug Price by Type (2014-2020)
4.2 Global Dermatology Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Dermatology Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Dermatology Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Dermatology Drug Price Forecast by Type (2021-2026)
5 Global Dermatology Drug Market Size by Application
5.1 Global Dermatology Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Dermatology Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Dermatology Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Dermatology Drug Price by Application (2015-2020)
5.2 Global Dermatology Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Dermatology Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Dermatology Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Dermatology Drug Price Forecast by Application (2021-2026)
3 North America Dermatology Drug Market Facts & Figures
3.2 North America Dermatology Drug Sales Market Share by Company (2015-2020)
3.3 North America Dermatology Drug Sales Market Share by Type (2015-2020)
3.4 North America Dermatology Drug Sales Market Share by Application (2015-2020)
4 Europe Dermatology Drug Market Facts & Figures
4.2 Europe Dermatology Drug Sales Market Share by Company (2015-2020)
4.3 Europe Dermatology Drug Sales Market Share by Type (2015-2020)
4.4 Europe Dermatology Drug Sales Market Share by Application (2015-2020)
5 China Dermatology Drug Market Facts & Figures
5.2 China Dermatology Drug Sales Market Share by Company (2015-2020)
5.3 China Dermatology Drug Sales Market Share by Type (2015-2020)
5.4 China Dermatology Drug Sales Market Share by Application (2015-2020)
6 Japan Dermatology Drug Market Facts & Figures
6.2 Japan Dermatology Drug Sales Market Share by Company (2015-2020)
6.3 Japan Dermatology Drug Sales Market Share by Type (2015-2020)
6.4 Japan Dermatology Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Dermatology Drug Market Facts & Figures
7.2 Southeast Asia Dermatology Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Dermatology Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Dermatology Drug Sales Market Share by Application (2015-2020)
8 India Dermatology Drug Market Facts & Figures
8.2 India Dermatology Drug Sales Market Share by Company (2015-2020)
8.3 India Dermatology Drug Sales Market Share by Type (2015-2020)
8.4 India Dermatology Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Dermatology Drug Business
12.1 AbbVie
12.1.1 AbbVie Dermatology Drug Corporation Information
12.1.2 AbbVie Dermatology Drug Business Overview and Total Revenue
12.1.3 AbbVie Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Dermatology Drug Products Offered
12.1.5 AbbVie Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Dermatology Drug Corporation Information
12.2.2 Johnson & Johnson Dermatology Drug Business Overview and Total Revenue
12.2.3 Johnson & Johnson Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Johnson & Johnson Dermatology Drug Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Bayer
12.3.1 Bayer Dermatology Drug Corporation Information
12.3.2 Bayer Dermatology Drug Business Overview and Total Revenue
12.3.3 Bayer Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Dermatology Drug Products Offered
12.3.5 Bayer Recent Development
12.4 Galderma
12.4.1 Galderma Dermatology Drug Corporation Information
12.4.2 Galderma Dermatology Drug Business Overview and Total Revenue
12.4.3 Galderma Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Galderma Dermatology Drug Products Offered
12.4.5 Galderma Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Dermatology Drug Corporation Information
12.5.2 Bristol-Myers Squibb Dermatology Drug Business Overview and Total Revenue
12.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bristol-Myers Squibb Dermatology Drug Products Offered
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Novartis
12.6.1 Novartis Dermatology Drug Corporation Information
12.6.2 Novartis Dermatology Drug Business Overview and Total Revenue
12.6.3 Novartis Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Dermatology Drug Products Offered
12.6.5 Novartis Recent Development
12.7 Pfizer
12.7.1 Pfizer Dermatology Drug Corporation Information
12.7.2 Pfizer Dermatology Drug Business Overview and Total Revenue
12.7.3 Pfizer Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Pfizer Dermatology Drug Products Offered
12.7.5 Pfizer Recent Development
12.8 Merz Pharma
12.8.1 Merz Pharma Dermatology Drug Corporation Information
12.8.2 Merz Pharma Dermatology Drug Business Overview and Total Revenue
12.8.3 Merz Pharma Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merz Pharma Dermatology Drug Products Offered
12.8.5 Merz Pharma Recent Development
12.9 Valeant
12.9.1 Valeant Dermatology Drug Corporation Information
12.9.2 Valeant Dermatology Drug Business Overview and Total Revenue
12.9.3 Valeant Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Valeant Dermatology Drug Products Offered
12.9.5 Valeant Recent Development
12.10 LEO Pharma
12.10.1 LEO Pharma Dermatology Drug Corporation Information
12.10.2 LEO Pharma Dermatology Drug Business Overview and Total Revenue
12.10.3 LEO Pharma Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 LEO Pharma Dermatology Drug Products Offered
12.10.5 LEO Pharma Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Dermatology Drug Corporation Information
12.11.2 GlaxoSmithKline Dermatology Drug Business Overview and Total Revenue
12.11.3 GlaxoSmithKline Dermatology Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlaxoSmithKline Dermatology Drug Products Offered
12.11.5 GlaxoSmithKline Recent Development
13 Dermatology Drug Manufacturing Cost Analysis
13.1 Dermatology Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dermatology Drug
13.4 Dermatology Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dermatology Drug Distributors List
14.3 Dermatology Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dermatology Drug Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Dermatology Drug Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Dermatology Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Dermatology Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Dermatology Drug Players to Combat Covid-19 Impact
Table 8. Global Market Dermatology Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Dermatology Drug Sales (K Units) by Region (2015-2020)
Table 10. Global Dermatology Drug Sales Market Share by Region (2015-2020)
Table 11. Global Dermatology Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Dermatology Drug Revenue Share by Region (2015-2020)
Table 13. Global Dermatology Drug Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Dermatology Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Dermatology Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Dermatology Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Dermatology Drug (K Units) of Key Companies (2015-2020)
Table 18. Global Dermatology Drug Sales Share by Company (2015-2020)
Table 19. Global Dermatology Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Dermatology Drug Revenue Share by Company (2015-2020)
Table 21. Global Dermatology Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology Drug as of 2019)
Table 22. Global Dermatology Drug Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Dermatology Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Dermatology Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Dermatology Drug Players
Table 27. Global Dermatology Drug Sales (K Units) by Type (2015-2020)
Table 28. Global Dermatology Drug Sales Share by Type (2015-2020)
Table 29. Global Dermatology Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Dermatology Drug Price (K Units) by Type (2015-2020)
Table 31. Global Dermatology Drug Sales Share by Type (2021-2026)
Table 32. Global Dermatology Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Dermatology Drug Revenue Share by Type (2021-2026)
Table 34. Global Dermatology Drug Price (K Units) by Type (2021-2026)
Table 35. Global Dermatology Drug Sales (K Units) by Application (2015-2020)
Table 36. Global Dermatology Drug Sales Share by Application (2015-2020)
Table 37. Global Dermatology Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Dermatology Drug Price (K Units) by Application (2015-2020)
Table 39. Global Dermatology Drug Sales (K Units) by Application (2021-2026)
Table 40. Global Dermatology Drug Sales Share by Application (2021-2026)
Table 41. Global Dermatology Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Dermatology Drug Revenue Share by Application (2021-2026)
Table 43. Global Dermatology Drug Price (K Units) by Application (2021-2026)
Table 44. United States Dermatology Drug Sales (K Units) by Company (2015-2020)
Table 45. United States Dermatology Drug Sales Market Share by Company (2015-2020)
Table 46. United States Dermatology Drug Sales (K Units) by Type (2015-2020)
Table 47. United States Dermatology Drug Sales Market Share by Type (2015-2020)
Table 48. United States Dermatology Drug Sales (K Units) by Application (2015-2020)
Table 49. United States Dermatology Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Dermatology Drug Sales (K Units) by Company (2015-2020)
Table 51. Europe Dermatology Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Dermatology Drug Sales (K Units) by Type (2015-2020)
Table 53. Europe Dermatology Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Dermatology Drug Sales (K Units) by Application (2015-2020)
Table 55. Europe Dermatology Drug Sales Market Share by Type (2015-2020)
Table 56. China Dermatology Drug Sales (K Units) by Company (2015-2020)
Table 57. China Dermatology Drug Sales Market Share by Company (2015-2020)
Table 58. China Dermatology Drug Sales (K Units) by Type (2015-2020)
Table 59. China Dermatology Drug Sales Market Share by Type (2015-2020)
Table 60. China Dermatology Drug Sales (K Units) by Application (2015-2020)
Table 61. China Dermatology Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Dermatology Drug Sales (K Units) by Company (2015-2020)
Table 63. Japan Dermatology Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Dermatology Drug Sales (K Units) by Type (2015-2020)
Table 65. Japan Dermatology Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Dermatology Drug Sales (K Units) by Application (2015-2020)
Table 67. Japan Dermatology Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Dermatology Drug Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Dermatology Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Dermatology Drug Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Dermatology Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Dermatology Drug Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Dermatology Drug Sales Market Share by Application (2015-2020)
Table 74. India Dermatology Drug Sales (K Units) by Company (2015-2020)
Table 75. India Dermatology Drug Sales Market Share by Company (2015-2020)
Table 76. India Dermatology Drug Sales (K Units) by Type (2015-2020)
Table 77. India Dermatology Drug Sales Market Share by Type (2015-2020)
Table 78. India Dermatology Drug Sales (K Units) by Application (2015-2020)
Table 79. India Dermatology Drug Sales Market Share by Application (2015-2020)
Table 80. AbbVie Corporation Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. AbbVie Dermatology Drug Product
Table 84. AbbVie Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Dermatology Drug Product
Table 89. Johnson & Johnson Recent Development
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bayer Dermatology Drug Product
Table 94. Bayer Recent Development
Table 95. Galderma Corporation Information
Table 96. Galderma Description and Business Overview
Table 97. Galderma Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Galderma Dermatology Drug Product
Table 99. Galderma Recent Development
Table 100. Bristol-Myers Squibb Corporation Information
Table 101. Bristol-Myers Squibb Description and Business Overview
Table 102. Bristol-Myers Squibb Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Bristol-Myers Squibb Dermatology Drug Product
Table 104. Bristol-Myers Squibb Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Novartis Dermatology Drug Product
Table 109. Novartis Recent Development
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Pfizer Dermatology Drug Product
Table 114. Pfizer Recent Development
Table 115. Merz Pharma Corporation Information
Table 116. Merz Pharma Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Merz Pharma Description and Business Overview
Table 118. Merz Pharma Dermatology Drug Product
Table 119. Merz Pharma Recent Development
Table 120. Valeant Corporation Information
Table 121. Valeant Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Valeant Description and Business Overview
Table 123. Valeant Dermatology Drug Product
Table 124. Valeant Recent Development
Table 125. LEO Pharma Corporation Information
Table 126. LEO Pharma Description and Business Overview
Table 127. LEO Pharma Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. LEO Pharma Dermatology Drug Product
Table 129. LEO Pharma Recent Development
Table . GlaxoSmithKline Corporation Information
Table . GlaxoSmithKline Description and Business Overview
Table . GlaxoSmithKline Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . GlaxoSmithKline Dermatology Drug Product
Table . GlaxoSmithKline Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Dermatology Drug Distributors List
Table 138. Dermatology Drug Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatology Drug Product Picture
Figure 2. Global Dermatology Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dermatology Drug Market Share by Application in 2020 & 2026
Figure 6. Psoriasis Examples
Figure 7. Skin Infections Examples
Figure 8. Acne Examples
Figure 9. Dermatitis Examples
Figure 10. Other Examples
Figure 11. Global Dermatology Drug Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Dermatology Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Dermatology Drug Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Dermatology Drug Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Dermatology Drug Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Dermatology Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Dermatology Drug Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Dermatology Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Dermatology Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Dermatology Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Dermatology Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Dermatology Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Dermatology Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Dermatology Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Dermatology Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Dermatology Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Dermatology Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Dermatology Drug Players Market Share by Revenue in Dermatology Drug 2015 & 2019
Figure 29. Dermatology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Dermatology Drug Revenue Share by Type (2015-2020)
Figure 31. Global Dermatology Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Dermatology Drug Revenue Share by Application (2015-2020)
Figure 33. Global Dermatology Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Dermatology Drug Sales Market Share by Type in 2019
Figure 35. United States Dermatology Drug Sales Market Share by Type in 2019
Figure 36. Europe Dermatology Drug Sales Market Share by Company in 2019
Figure 37. Europe Dermatology Drug Sales Market Share by Type in 2019
Figure 38. Europe Dermatology Drug Sales Market Share by Application in 2019
Figure 39. China Dermatology Drug Sales Market Share by Company in 2019
Figure 40. China Dermatology Drug Sales Market Share by Type in 2019
Figure 41. China Dermatology Drug Sales Market Share by Application in 2019
Figure 42. Japan Dermatology Drug Sales Market Share by Company in 2019
Figure 43. Japan Dermatology Drug Sales Market Share by Type in 2019
Figure 44. Japan Dermatology Drug Sales Market Share by Application in 2019
Figure 45. Southeast Asia Dermatology Drug Sales Market Share by Company in 2019
Figure 46. Southeast Asia Dermatology Drug Sales Market Share by Type in 2019
Figure 47. Southeast Asia Dermatology Drug Sales Market Share by Application in 2019
Figure 48. India Dermatology Drug Sales Market Share by Company in 2019
Figure 49. India Dermatology Drug Sales Market Share by Type in 2019
Figure 50. India Dermatology Drug Sales Market Share by Application in 2019
Figure 51. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Galderma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Merz Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. LEO Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Dermatology Drug
Figure 64. Manufacturing Process Analysis of Dermatology Drug
Figure 65. Dermatology Drug Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
皮膚科OTC薬の世界市場レポート2020 A recently published report by QY Research titled Global Dermatology OTC Medications Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides…- 皮膚科レーザーの世界市場レポート2020 Market Analysis and Insights: Global Dermatology Lasers Market The global Dermatology Lasers market was valued at US$ 1895.6 million in 2019 and will reach US$ 4789.8 million by the end of 2026, growing at a CAGR of 14.0% during 2020-2026. Global Dermatology Lasers Scope and Market Size The global D…
- 皮膚科治療装置の世界市場レポート2020 Market Analysis and Insights: Global Dermatology Therapeutics Devices Market The global Dermatology Therapeutics Devices market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Dermatology Therapeutics Devices Sc…
- 皮膚科用レーザーの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Dermatology Laser market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dermatology Laser m…
- 皮膚科用デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dermatology Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dermatology Devices mark…